Here are four points:
1. This includes the filing and the $1 closing bid price requirement.
2. The company must file its Forms 10-Q for the periods ended March 31 and June 30 with the SEC by Oct. 31 to posses continued Nasdaq listing.
3. Additionally, Amedica must show a closing bid price of $1 minimum per share for at least 10 consecutive business days by Nov. 30.
4. While Amedica is working to demonstrate compliance, it will not necessarily be able to do so in the time allotted.
More articles on devices:
OrthoPediatrics Corp. closes initial public offering of 4.6M shares: 5 insights
Arthrex to build $30M manufacturing plant in South Carolina: 5 insights
Johnson & Johnson medical device segment reports 4.9% sales growth in 2Q 2017 – to see greater growth in 3Q
